ATE383853T1 - Arylessigsäuren und verwandte verbindungen zur behandlung von alzheimer-krankheit - Google Patents
Arylessigsäuren und verwandte verbindungen zur behandlung von alzheimer-krankheitInfo
- Publication number
- ATE383853T1 ATE383853T1 AT05758960T AT05758960T ATE383853T1 AT E383853 T1 ATE383853 T1 AT E383853T1 AT 05758960 T AT05758960 T AT 05758960T AT 05758960 T AT05758960 T AT 05758960T AT E383853 T1 ATE383853 T1 AT E383853T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- arylestic
- alzheimer
- disease
- acids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0416508.0A GB0416508D0 (en) | 2004-07-23 | 2004-07-23 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE383853T1 true ATE383853T1 (de) | 2008-02-15 |
Family
ID=32922716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05758960T ATE383853T1 (de) | 2004-07-23 | 2005-07-19 | Arylessigsäuren und verwandte verbindungen zur behandlung von alzheimer-krankheit |
Country Status (10)
Country | Link |
---|---|
US (1) | US20080300261A1 (de) |
EP (1) | EP1773315B1 (de) |
JP (1) | JP2008507498A (de) |
CN (1) | CN1993120B (de) |
AT (1) | ATE383853T1 (de) |
AU (1) | AU2005264004A1 (de) |
CA (1) | CA2574359A1 (de) |
DE (1) | DE602005004416T2 (de) |
GB (1) | GB0416508D0 (de) |
WO (1) | WO2006008558A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1650183A1 (de) * | 2004-10-21 | 2006-04-26 | Cellzome Ag | (Benzyloxy-biphenyl)essigsäuren, ihre Derivate und Verwendung in der Therapie |
DK1847524T3 (da) | 2006-04-21 | 2010-01-11 | Cellzome Ltd | Terphenylderivater til behandling af Alzheimers sygdom |
PL1849762T3 (pl) * | 2006-04-21 | 2009-12-31 | Cellzome Ltd | Podstawione kwasy bifenylo-karboksylowe i ich pochodne |
EP2121633A2 (de) | 2007-02-12 | 2009-11-25 | Merck & Co., Inc. | Piperazinderivate zur behandlung von alzheimer-krankheit und verwandten leiden |
US20110040094A1 (en) * | 2007-09-14 | 2011-02-17 | Envivo Pharmaceuticals, Inc. | 1,3,4-trisubstituted benzenes |
JP5543353B2 (ja) * | 2007-10-19 | 2014-07-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | γ−セクレターゼのアミド結合調節物質 |
AU2008312371B2 (en) * | 2007-10-19 | 2013-06-20 | Janssen Pharmaceutica, N.V. | Amine linked modulators of gamma-secretase |
WO2009052334A1 (en) * | 2007-10-19 | 2009-04-23 | Janssen Pharmaceutica, N.V. | Carbon linked modulators of y-secretase |
US8252935B2 (en) * | 2007-10-19 | 2012-08-28 | Janssen Pharmaceutica N.V. | Piperidinyl and piperazinyl modulators of γ-secretase |
JP2011507909A (ja) * | 2007-12-20 | 2011-03-10 | エンビボ ファーマシューティカルズ インコーポレイテッド | 四置換ベンゼン |
US7968725B2 (en) * | 2008-07-22 | 2011-06-28 | Janssen Pharmaceutica N.V. | Pyridinyl modulators of γ-secretase |
US8575150B2 (en) | 2008-12-16 | 2013-11-05 | Merck Sharp & Dohme Corp. | Triazole derivatives for treatment of Alzheimer's disease |
WO2010138901A1 (en) * | 2009-05-29 | 2010-12-02 | Biogen Idec Ma Inc | Carboxylic acid-containing compounds, derivatives thereof, and related methods of use |
US8586776B2 (en) * | 2009-11-05 | 2013-11-19 | Fibrostatin, S.L. | GPBP inhibition using Q2 peptidomimetics |
JPWO2011062194A1 (ja) | 2009-11-18 | 2013-04-04 | 武田薬品工業株式会社 | アミノピリジン誘導体 |
US9802927B2 (en) | 2015-06-10 | 2017-10-31 | Denali Therapeutics, Inc. | Oxadiazine compounds and methods of use thereof |
KR102486298B1 (ko) | 2016-02-09 | 2023-01-06 | 인벤티스바이오 엘엘씨 | 인돌아민-2,3-디옥시게나아제(ido)의 억제제 |
WO2023146513A1 (en) * | 2022-01-25 | 2023-08-03 | Vivace Therapeutics, Inc. | Compounds and methods of use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08325182A (ja) * | 1995-05-31 | 1996-12-10 | Fuji Yakuhin Kogyo Kk | 置換テルフェニル誘導体とそれらを含有する抗血栓剤 |
CO4960662A1 (es) * | 1997-08-28 | 2000-09-25 | Novartis Ag | Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados |
FR2838439B1 (fr) * | 2002-04-11 | 2005-05-20 | Sanofi Synthelabo | Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant |
GB0225548D0 (en) * | 2002-11-01 | 2002-12-11 | Glaxo Group Ltd | Compounds |
-
2004
- 2004-07-23 GB GBGB0416508.0A patent/GB0416508D0/en not_active Ceased
-
2005
- 2005-07-19 AU AU2005264004A patent/AU2005264004A1/en not_active Abandoned
- 2005-07-19 JP JP2007522039A patent/JP2008507498A/ja not_active Withdrawn
- 2005-07-19 EP EP05758960A patent/EP1773315B1/de not_active Not-in-force
- 2005-07-19 WO PCT/GB2005/050114 patent/WO2006008558A1/en active IP Right Grant
- 2005-07-19 US US11/658,242 patent/US20080300261A1/en not_active Abandoned
- 2005-07-19 DE DE602005004416T patent/DE602005004416T2/de active Active
- 2005-07-19 AT AT05758960T patent/ATE383853T1/de not_active IP Right Cessation
- 2005-07-19 CN CN2005800249403A patent/CN1993120B/zh not_active Expired - Fee Related
- 2005-07-19 CA CA002574359A patent/CA2574359A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2008507498A (ja) | 2008-03-13 |
CN1993120A (zh) | 2007-07-04 |
CA2574359A1 (en) | 2006-01-26 |
GB0416508D0 (en) | 2004-08-25 |
WO2006008558A1 (en) | 2006-01-26 |
US20080300261A1 (en) | 2008-12-04 |
DE602005004416D1 (de) | 2008-03-06 |
DE602005004416T2 (de) | 2009-01-08 |
EP1773315A1 (de) | 2007-04-18 |
AU2005264004A1 (en) | 2006-01-26 |
CN1993120B (zh) | 2010-05-05 |
EP1773315B1 (de) | 2008-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE383853T1 (de) | Arylessigsäuren und verwandte verbindungen zur behandlung von alzheimer-krankheit | |
ATE455763T1 (de) | Piperidine und verwandte verbindungen zur behandlung von alzheimer-krankheit | |
ATE409176T1 (de) | 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen | |
ATE550338T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
ATE506951T1 (de) | Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit | |
DE602005022113D1 (de) | Phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
ATE457989T1 (de) | Bi- und trizyklische substituierte phenyl- methanone als inhibitoren von glycin-i (glyt-1)- transportern zur behandlung der alzheimer- krankheit | |
ATE396174T1 (de) | Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten | |
DE602004014170D1 (de) | Benzylether- und benzylamino-beta-sekretase-hemmer zur behandlung von alzheimer-krankheit | |
TW200420550A (en) | Thiazole compounds for the treatment of neurodegenerative disorders | |
DE502005008058D1 (de) | Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen | |
ATE529427T1 (de) | Ä1h-indol-5-yl)-heteroaryloxyü-(1-aza-bicyclo- ä3.3.1ü-nonane als cholinergische liganden des n- achr zur behandlung psychotischer und neurodegenerativer leiden | |
ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
ATE512147T1 (de) | Makrozyklische aminiopyridyl-beta-sekretase- hemmer zur behandlung von morbus alzheimer | |
ATE437855T1 (de) | (4,5,6,7-tetrahydro-1h-indol-7- yl)essigsäurederivate zur behandlung von alzheimer-krankheit | |
ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
ATE399758T1 (de) | Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten | |
ATE530525T1 (de) | Piperidine und verwandte verbindungen zur behandlung von demenz | |
ATE464048T1 (de) | Behandlung von alzheimer-krankheit und verwandten zuständen | |
ATE538796T1 (de) | Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit | |
ATE402150T1 (de) | Pyrazolaminverbindungen zur behandlung neurodegenerativer erkrankungen | |
ATE549923T1 (de) | Makrozyklische spiropiperidin-beta-sekretase- hemmer zur behandlung von morbus alzheimer | |
ATE519740T1 (de) | Tetrahydroindolderivate zur behandlung von alzheimer-krankheit | |
DE602004030661D1 (de) | Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |